Eight Years of Decreased MRSA Healthcare-Associated Infections Associated with Veterans Affairs Prevention Initiative
Arlington, VA, January 5, 2017
The Department of Veterans Affairs' Veterans Health Administration’s campaign to limit healthcare facility-associated infections (HAIs) of methicillin-resistant Staphylococcus aureus (MRSA) continues to make significant progress, according to a study published in the January issue of the American Journal of Infection Control, the official journal of the Association for Professionals in Infection Control and Epidemiology (APIC).
The new study, by Martin E. Evans, MD, and colleagues from the Veterans Health Administration, found that between October 2007 and September 2015 monthly HAI rates dropped 87 percent in intensive care units (ICUs), 80.1 percent in non-ICUs, and 80.9 percent in spinal cord injury units (SCIUs). In long-term care facilities (LTCFs), rates fell 49.4 percent during the period of July 2009 to September 2015. During September 2015, only two MRSA HAIs were reported in ICUs, 20 in non-ICUs (with three in SCIUs), and 31 in LTCFs nationwide.
“Understanding how and why rates of MRSA have diminished in recent years is essential for the continued progress of effective prevention programs,” said lead study author Martin E. Evans, MD. “As we seek to protect patients from MRSA and other resistant organisms, our study supports the need for strong infection prevention programs at every healthcare facility.”
Prior to 2007, MRSA HAI rates were unacceptably high in VA facilities leading the VA to implement the MRSA Prevention Initiative nationwide in October 2007. Results from a previous study published by the researchers demonstrated a significant decline in MRSA transmissions and MRSA HAIs between October 2007 and June 2012 in acute care medical centers, between October 2007 and June 2011 in SCIUs, and between July 2009 and December 2012 in LTCFs. The current study updates and supports these continuing trends in MRSA transmission and HAIs through September 2015, thus comprising an eight-year study period.
The VA program included having a dedicated MRSA prevention coordinator at each facility to oversee a bundle of interventions which included: universal active surveillance (screening) on admission, unit-to-unit transfer, and discharge; contact precautions for those colonized or infected with MRSA; adherence to hand hygiene; and institutional culture change where infection prevention became everyone’s business.
The authors speculated that the focused attention on MRSA infections helped motivate healthcare workers to practice better infection prevention and control measures. “We speculate that active surveillance was the primary driver of the downward trends seen in the VA, because MRSA HAI rates had not changed prior to October 2007 when the initiative was fully implemented, even though formal recommendations for hand hygiene and device-related infection control bundles had been in place for several years.”
The study used monthly reports generated by nationally distributed software, which extracts MRSA nares screening, clinical culture and patient movement data, to analyze MRSA and HAI data from the VA between October 2007 and September 2015.
MRSA causes a range of illnesses, from skin and wound infections to pneumonia and bloodstream infections that can lead to sepsis and death. Staph bacteria, including MRSA, are one of the most common causes of healthcare-associated infections. Studies show that 33 percent of people carry staph in their nose, usually without any illness, while two out of 100 people carry MRSA, according to the Centers for Disease Control and Prevention.
Visit www.apic.org to learn more information about preventing infections in healthcare facilities.
Notes for editors
The article is "Eight years of decreased methicillin-resistant Staphylococcus aureus health care-associated infections associated with a Veterans Affairs prevention initiative," by Martin E. Evans, Stephen M. Kralovic, Loretta A. Simbartl, Rajiv Jain, and Gary A. Roselle (dx.doi.org/10.1016/j.ajic.2016.08.010). It appears in the American Journal of Infection Control, volume 45, issue 1 (January 2017), published by Elsevier.
About AJIC: American Journal of Infection Control
AJIC: American Journal of Infection Control covers key topics and issues in infection control and epidemiology. Infection preventionists, including physicians, nurses, and epidemiologists, rely on AJIC for peer-reviewed articles covering clinical topics as well as original research. As the official publication of APIC, AJIC is the foremost resource on infection control, epidemiology, infectious diseases, quality management, occupational health, and disease prevention. AJIC also publishes infection control guidelines from APIC and the CDC. Published by Elsevier, AJIC is included in MEDLINE and CINAHL.
APIC’s mission is to create a safer world through prevention of infection. The association’s more than 15,000 members direct infection prevention programs that save lives and improve the bottom line for hospitals and other healthcare facilities. APIC advances its mission through patient safety, implementation science, competencies and certification, advocacy, and data standardization. Visit APIC online at www.apic.org. Follow APIC on Twitter: www.twitter.com/apic and Facebook: www.facebook.com/APICInfectionPreventionandYou . For information on what patients and families can do, visit APIC’s Infection Prevention and You website at www.apic.org/infectionpreventionandyou.
Elsevier is a global information analytics business that helps institutions and professionals advance healthcare, open science and improve performance for the benefit of humanity. Elsevier provides digital solutions and tools in the areas of strategic research management, R&D performance, clinical decision support and professional education, including ScienceDirect, Scopus, SciVal, ClinicalKey and Sherpath. Elsevier publishes over 2,500 digitized journals, including The Lancet and Cell, more than 38,000 e-book titles and many iconic reference works, including Gray's Anatomy. Elsevier is part of RELX Group, a global provider of information and analytics for professionals and business customers across industries. www.elsevier.com